Literature DB >> 28342882

Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.

Mirette Habib1, Elijah Mak2, Silvy Gabel2, Li Su2, Guy Williams3, Adam Waldman4, Katie Wells1, Karen Ritchie5, Craig Ritchie6, John T O'Brien7.   

Abstract

It is well established that the neurodegenerative process of Alzheimer's disease (AD) begins many years before symptom onset. This preclinical phase provides a crucial time-window for therapeutic intervention, though this requires biomarkers that could evaluate the efficacy of future disease-modification treatments in asymptomatic individuals. The last decade has witnessed a proliferation of studies characterizing the temporal sequence of the earliest functional and structural brain imaging changes in AD. These efforts have focused on studying individuals who are highly vulnerable to develop AD, such as those with familial genetic mutations, susceptibility genes (i.e. apolipoprotein epsilon-4 allele), and/or a positive family history of AD. In this paper, we review the rapidly growing literature of functional imaging changes in cognitively intact individuals who are middle-aged: positron emission tomography (PET) studies of amyloid deposition, glucose metabolism, as well as arterial spin labeling (ASL), task-dependent, resting-state functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) studies. The prevailing evidence points to early brain functional changes in the relative absence of cognitive impairment and structural atrophy, although there is marked variability in the directionality of the changes, which could, in turn, be related to antagonistic pleiotropy early in life. A common theme across studies relates to the spatial extent of these changes, most of which overlap with brain regions that are implicated in established AD. Notwithstanding several methodological caveats, functional imaging techniques could be preferentially sensitive to the earliest events of AD pathology prior to macroscopic grey matter loss and clinical manifestations of AD. We conclude that while these techniques have great potential to serve as biomarkers to identify at-risk individuals, more longitudinal studies with greater sample size and robust correction for multiple comparisons are still warranted to establish their utility.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Cognitive impairment; Functional; Magnetic resonance imaging; Neurodegeneration; Neuroimaging; Positron emission tomography; Preclinical dementia

Mesh:

Substances:

Year:  2017        PMID: 28342882     DOI: 10.1016/j.arr.2017.03.004

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  13 in total

1.  The Lifespan Human Connectome Project in Aging: An overview.

Authors:  Susan Y Bookheimer; David H Salat; Melissa Terpstra; Beau M Ances; Deanna M Barch; Randy L Buckner; Gregory C Burgess; Sandra W Curtiss; Mirella Diaz-Santos; Jennifer Stine Elam; Bruce Fischl; Douglas N Greve; Hannah A Hagy; Michael P Harms; Olivia M Hatch; Trey Hedden; Cynthia Hodge; Kevin C Japardi; Taylor P Kuhn; Timothy K Ly; Stephen M Smith; Leah H Somerville; Kâmil Uğurbil; Andre van der Kouwe; David Van Essen; Roger P Woods; Essa Yacoub
Journal:  Neuroimage       Date:  2018-10-15       Impact factor: 6.556

2.  Early-but Not Late-Onset Hypertension Is Related to Midlife Cognitive Function.

Authors:  Karri Suvila; Joao A C Lima; Yuichiro Yano; Zaldy S Tan; Susan Cheng; Teemu J Niiranen
Journal:  Hypertension       Date:  2021-01-19       Impact factor: 9.897

3.  Resting-State Functional Network Topology Alterations of the Occipital Lobe Associated With Attention Impairment in Isolated Rapid Eye Movement Behavior Disorder.

Authors:  Chaofan Geng; Shenghui Wang; Zhonglin Li; Pengfei Xu; Yingying Bai; Yao Zhou; Xinyu Zhang; Yongli Li; Jiewen Zhang; Hongju Zhang
Journal:  Front Aging Neurosci       Date:  2022-04-01       Impact factor: 5.702

4.  Impaired memory-guided attention in asymptomatic APOE4 carriers.

Authors:  Jacqueline Zimmermann; Claude Alain; Chris Butler
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

5.  Network Modeling Sex Differences in Brain Integrity and Metabolic Health.

Authors:  Janelle T Foret; Maria Dekhtyar; James H Cole; Drew D Gourley; Marie Caillaud; Hirofumi Tanaka; Andreana P Haley
Journal:  Front Aging Neurosci       Date:  2021-06-29       Impact factor: 5.750

6.  Cerebral blood flow changes in remitted early- and late-onset depression patients.

Authors:  Wenxiang Liao; Ze Wang; Xiangrong Zhang; Hao Shu; Zan Wang; Duan Liu; Zhijun Zhang
Journal:  Oncotarget       Date:  2017-07-12

7.  Brain connectivity during Alzheimer's disease progression and its cognitive impact in a transgenic rat model.

Authors:  Emma Muñoz-Moreno; Raúl Tudela; Xavier López-Gil; Guadalupe Soria
Journal:  Netw Neurosci       Date:  2020-04-01

8.  Model-based whole-brain effective connectivity to study distributed cognition in health and disease.

Authors:  Matthieu Gilson; Gorka Zamora-López; Vicente Pallarés; Mohit H Adhikari; Mario Senden; Adrià Tauste Campo; Dante Mantini; Maurizio Corbetta; Gustavo Deco; Andrea Insabato
Journal:  Netw Neurosci       Date:  2020-04-01

9.  Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions.

Authors:  Félix Bermejo-Pareja; Teodoro Del Ser; Meritxell Valentí; Mónica de la Fuente; Fernando Bartolome; Eva Carro
Journal:  Alzheimers Dement       Date:  2020-06-16       Impact factor: 21.566

10.  Coupling relationship between glucose and oxygen metabolisms to differentiate preclinical Alzheimer's disease and normal individuals.

Authors:  Changchang Ding; Wenying Du; Qi Zhang; Luyao Wang; Ying Han; Jiehui Jiang
Journal:  Hum Brain Mapp       Date:  2021-07-22       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.